-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$11.33703.55% Upside
Actinium Pharmaceuticals, Inc. Frequently Asked Questions
-
What analysts cover Actinium Pharmaceuticals, Inc.?
Actinium Pharmaceuticals, Inc. has been rated by research analysts at Maxim Group, H.C. Wainwright, Stephens in the past 90 days.